{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:13:08Z","timestamp":1794409988224,"version":"4.9.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanghai Super Postdoctoral Incentive Program"},{"name":"NSFC-RGC Joint Research Scheme"},{"name":"National Key Research and Development Program of China"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Open Research Fund of State Key Laboratory of Genetics and Development of Complex Phenotypes"},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00784-6","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T09:47:05Z","timestamp":1776160025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The MST4\u201314-3-3\u03b6 complex promotes pancreatic cancer by activating YAP"],"prefix":"10.1186","volume":"21","author":[{"given":"Luyang","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shisi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingquan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaocai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"784_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jama.2021.13027","volume":"326","author":"W Park","year":"2021","unstructured":"Park W, Chawla A, O\u2019Reilly EM. Pancreatic Cancer: A Review. Jama-J Am Med Assoc. 2021;326:851\u201362.","journal-title":"Jama-J Am Med Assoc"},{"key":"784_CR2","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1136\/gutjnl-2018-318086","volume":"68","author":"S Singh","year":"2019","unstructured":"Singh S, Hasselluhn MC, Neesse A. A tangled tale of molecular subtypes in pancreatic cancer. Gut. 2019;68:953\u2013.","journal-title":"Gut"},{"key":"784_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","volume":"163","author":"LD Wood","year":"2022","unstructured":"Wood LD, Canto MI, Jaffee EM, Simeone DM. Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment. Gastroenterology. 2022;163:386\u2013.","journal-title":"Gastroenterology"},{"key":"784_CR4","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/S0140-6736(25)00261-2","volume":"405","author":"TF Stoop","year":"2025","unstructured":"Stoop TF, Javed AA, Oba A. Pancreatic cancer (405, pg 1182, 2025). Lancet. 2025;405:1742\u20131742.","journal-title":"Lancet"},{"key":"784_CR5","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, di Magliano MP, Maitra A. Pancreatic cancer: Advances and challenges. Cell. 2023;186:1729\u201354.","journal-title":"Cell"},{"key":"784_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","volume":"18","author":"AP Klein","year":"2021","unstructured":"Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastro Hepat. 2021;18:493\u2013502.","journal-title":"Nat Rev Gastro Hepat"},{"key":"784_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41575-023-00840-w","volume":"21","author":"ZI Hu","year":"2024","unstructured":"Hu ZI, O\u2019Reilly EM. Therapeutic developments in pancreatic cancer. Nat Rev Gastro Hepat. 2024;21:7\u201324.","journal-title":"Nat Rev Gastro Hepat"},{"key":"784_CR8","doi-asserted-by":"crossref","unstructured":"Froeling FEM, Valle J, Upstill-Goddard R, Grimwood P, Westwood P, Dreyer SB, et al. Therapeutic development platform for pancreatic cancer in the UK national health service: Lessons learned and initial results from Precision-Panc. Cancer Res 2024;84.","DOI":"10.1158\/1538-7445.PANCA2023-PR04"},{"key":"784_CR9","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41575-018-0005-x","volume":"15","author":"JP Neoptolemos","year":"2018","unstructured":"Neoptolemos JP, Kleeff J, Michl P, Costello E, Greenhalf W, Palmer DH. Therapeutic developments in pancreatic cancer: current and future perspectives. Nat Rev Gastro Hepat. 2018;15:332\u201347.","journal-title":"Nat Rev Gastro Hepat"},{"key":"784_CR10","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.4161\/cc.22322","volume":"11","author":"FX Yu","year":"2012","unstructured":"Yu FX, Mo JS, Guan KL. Upstream regulators of the Hippo pathway. Cell Cycle. 2012;11:4097\u20138.","journal-title":"Cell Cycle"},{"key":"784_CR11","doi-asserted-by":"crossref","unstructured":"Su WJ, Zhu SK, Chen K, Yang HJ, Tian MW, Fu Q, et al. Overexpressed WDR3 induces the activation of Hippo pathway by interacting with GATA4 in pancreatic cancer. J Exp Clin Canc Res 2021;40.","DOI":"10.1186\/s13046-021-01879-w"},{"key":"784_CR12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.omtn.2021.07.004","volume":"26","author":"M Xu","year":"2021","unstructured":"Xu M, Cui R, Ye LH, Wang YK, Wang XJ, Zhang QQ, et al. LINC00941 promotes glycolysis in pancreatic cancer by modulating the Hippo pathway. Mol Ther Nucl Acids. 2021;26:280\u201394.","journal-title":"Mol Ther Nucl Acids"},{"key":"784_CR13","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/j.bbadis.2018.03.005","volume":"1864","author":"MT Zhang","year":"2018","unstructured":"Zhang MT, Zhao Y, Zhang YL, Wang DW, Gu SM, Feng W, et al. LncRNA UCA1 promotes migration and invasion in pancreatic cancer cells the Hippo pathway. Bba-Mol Basis Dis. 2018;1864:1770\u201382.","journal-title":"Bba-Mol Basis Dis"},{"key":"784_CR14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1158\/1538-7445.AM2018-23","volume":"78","author":"A Dey","year":"2018","unstructured":"Dey A. The tumor suppressor BAP1 regulates the Hippo pathway in pancreatic ductal adenocarcinoma. Cancer Res. 2018;78:23\u20134.","journal-title":"Cancer Res"},{"key":"784_CR15","doi-asserted-by":"publisher","first-page":"44466","DOI":"10.18632\/oncotarget.6298","volume":"6","author":"MY Chen","year":"2015","unstructured":"Chen MY, Wang M, Xu SM, Guo XJ, Jiang JX. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway. Oncotarget. 2015;6:44466\u201379.","journal-title":"Oncotarget"},{"key":"784_CR16","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.21873\/anticanres.13474","volume":"39","author":"D Ansari","year":"2019","unstructured":"Ansari D, Ohlsson H, Althini C, Bauden M, Zhou QM, Hu DY, et al. The Hippo Signaling Pathway in Pancreatic Cancer. Anticancer Res. 2019;39:3317\u201321.","journal-title":"Anticancer Res"},{"key":"784_CR17","doi-asserted-by":"crossref","unstructured":"Jiang ZD, Zhou CC, Cheng L, Yan B, Chen K, Chen X, et al. Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions. J Exp Clin Canc Res 2018;37.","DOI":"10.1186\/s13046-018-0740-4"},{"key":"784_CR18","doi-asserted-by":"crossref","unstructured":"Hao F, Xu QH, Wang J, Yu S, Chang HH, Sinnett-Smith J, et al. Lipophilic statins inhibit YAP nuclear localization, co-activator activity and colony formation in pancreatic cancer cells and prevent the initial stages of pancreatic ductal adenocarcinoma in mice. PLoS ONE 2019;14.","DOI":"10.1371\/journal.pone.0216603"},{"key":"784_CR19","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.7150\/thno.53438","volume":"11","author":"WH Mao","year":"2021","unstructured":"Mao WH, Mai J, Peng H, Wan JH, Sun T. YAP in pancreatic cancer: oncogenic role and therapeutic strategy. Theranostics. 2021;11:1753\u201362.","journal-title":"Theranostics"},{"key":"784_CR20","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.7150\/thno.42795","volume":"10","author":"Q Guo","year":"2020","unstructured":"Guo Q, Quan MY, Dong JL, Bai J, Wang J, Han R, et al. The WW domains dictate isoform-specific regulation of YAP1 stability and pancreatic cancer cell malignancy. Theranostics. 2020;10:4422\u201336.","journal-title":"Theranostics"},{"key":"784_CR21","doi-asserted-by":"publisher","first-page":"9121","DOI":"10.2147\/IJN.S464788","volume":"19","author":"YN Huang","year":"2024","unstructured":"Huang YN, Wang YF, Zheng TY, Nie S, Wang YL, Shen H, et al. Development of Dual Diagnostic-Therapeutic Nanoformulation Effective Against Pancreatic Cancer in Animal Model. Int J Nanomed. 2024;19:9121\u201343.","journal-title":"Int J Nanomed"},{"key":"784_CR22","doi-asserted-by":"crossref","unstructured":"Xie YP, Qin C, Zhang XY, Li ZR, Zhao BB, Li TY, et al. Nuclear localization of YAP in pancreatic cancer: More players besides Hippo pathway. Cancer Lett 2025;629.","DOI":"10.1016\/j.canlet.2025.217864"},{"key":"784_CR23","doi-asserted-by":"crossref","unstructured":"Liu ZH, Zhang CM, Gai YW, Su P, Wang BB, Liu P, et al. VCPIP1 facilitates pancreatic adenocarcinoma progression via Hippo\/YAP signaling. Cell Death Dis 2025;16.","DOI":"10.1038\/s41419-025-07746-2"},{"key":"784_CR24","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1158\/1541-7786.MCR-18-0910","volume":"17","author":"JJ Cui","year":"2019","unstructured":"Cui JJ, Zhou ZQ, Yang HY, Jiao F, Li N, Gao Y, et al. MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis. Mol Cancer Res. 2019;17:1316\u201325.","journal-title":"Mol Cancer Res"},{"key":"784_CR25","doi-asserted-by":"crossref","unstructured":"Sun Y, Jin X, Meng JP, Guo F, Chen TY, Zhao XY, et al. MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression. EMBO J 2023;42.","DOI":"10.15252\/embj.2023114558"},{"key":"784_CR26","doi-asserted-by":"crossref","unstructured":"Qin C, Zhao BB, Wang YY, Li ZR, Li TY, Zhao YT, et al. Extracellular vesicles miR-31-5p promotes pancreatic cancer chemoresistance via regulating LATS2-Hippo pathway and promoting SPARC secretion from pancreatic stellate cells. J Extracell Vesicles 2024;13.","DOI":"10.1002\/jev2.12488"},{"key":"784_CR27","doi-asserted-by":"crossref","unstructured":"Quan M, Chen ZQ, Jiao F, Xiao XY, Xia Q, Chen JD, et al. Lysine demethylase 2 (KDM2B) regulates hippo pathway via MOB1 to promote pancreatic ductal adenocarcinoma (PDAC) progression. J Exp Clin Canc Res 2020;39.","DOI":"10.1186\/s13046-019-1489-0"},{"key":"784_CR28","first-page":"1509","volume":"48","author":"N Pu","year":"2019","unstructured":"Pu N, Gao SS, Yin HL, Li JA, Wu WC, Fang Y, et al. Cell-intrinsic PD-1 Promotes Proliferation in Pancreatic Cancer Targeting CYR61\/CTGF Via Hippo Pathway. Pancreas. 2019;48:1509\u201310.","journal-title":"Pancreas"},{"key":"784_CR29","doi-asserted-by":"crossref","unstructured":"Getu AA, Zhou M, Cheng SY, Tan M. The mammalian Sterile 20-like kinase 4 (MST4) signaling in tumor progression: Implications for therapy. Cancer Lett 2023;563.","DOI":"10.1016\/j.canlet.2023.216183"},{"key":"784_CR30","doi-asserted-by":"crossref","unstructured":"Zhang XL, Song LL, Huang YX, Han SP, Hou M, Li HX. Downregulation of MST4 Underlies a Novel Inhibitory Role of MicroRNA Let-7a in the Progression of Retinoblastoma. Invest Ophth Vis Sci 2020;61.","DOI":"10.1167\/iovs.61.6.28"},{"key":"784_CR31","first-page":"8105","volume":"7","author":"HY Zhang","year":"2014","unstructured":"Zhang HY, Ma X, Peng SH, Nan X, Zhao HS. Differential expression of MST4, STK25 and PDCD10 between benign prostatic hyperplasia and prostate cancer. Int J Clin Exp Patho. 2014;7:8105\u201311.","journal-title":"Int J Clin Exp Patho"},{"key":"784_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/iub.2682","volume":"75","author":"XH Shi","year":"2023","unstructured":"Shi XH, Zou JW, Wang YH, Zhao J, Ye B, Qi QH, et al. MST4 as a novel therapeutic target for autophagy and radiosensitivity in gastric cancer. IUBMB Life. 2023;75:117\u201336.","journal-title":"IUBMB Life"},{"key":"784_CR33","doi-asserted-by":"crossref","unstructured":"An LW, Nie PP, Chen M, Tang Y, Zhang H, Guan JM, et al. MST4 kinase suppresses gastric tumorigenesis by limiting YAP activation via a non-canonical pathway. J Exp Med 2020;217.","DOI":"10.1084\/jem.20191817"},{"key":"784_CR34","doi-asserted-by":"publisher","first-page":"4463","DOI":"10.7150\/jca.60008","volume":"12","author":"MJ Dian","year":"2021","unstructured":"Dian MJ, Li J, Zhang XL, Li ZJ, Zhou Y, Zhou W, et al. MST4 negatively regulates the EMT, invasion and metastasis of HCC cells by inactivating PI3K\/AKT\/Snail1 axis. J Cancer. 2021;12:4463\u201377.","journal-title":"J Cancer"},{"key":"784_CR35","first-page":"50","volume":"20","author":"TZ Huang","year":"2018","unstructured":"Huang TZ, Kim CK, Alvarez A, Pangeni R, Wan XC, Xiao S, et al. Mst4 Phosphorylation of Atg4b Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in Glioblastoma. Neurooncology. 2018;20:50\u20131.","journal-title":"Neurooncology"},{"key":"784_CR36","doi-asserted-by":"publisher","first-page":"9353","DOI":"10.2147\/CMAR.S219689","volume":"11","author":"TY Li","year":"2019","unstructured":"Li TY, Deng L, He X, Jiang GG, Hu F, Ye SP, et al. MST4 Predicts Poor Prognosis And Promotes Metastasis By Facilitating Epithelial-Mesenchymal Transition In Gastric Cancer. Cancer Manag Res. 2019;11:9353\u201369.","journal-title":"Cancer Manag Res"},{"key":"784_CR37","doi-asserted-by":"crossref","unstructured":"Liu PW, Li L, Wang W, He CY, Xu CF. MST4 promotes proliferation, invasion, and metastasis of gastric cancer by enhancing autophagy. Heliyon 2023;9.","DOI":"10.2139\/ssrn.4345743"},{"key":"784_CR38","doi-asserted-by":"crossref","unstructured":"Arora R, Kim JH, Getu AA, Angajala A, Chen YL, Wang B, et al. MST4: A potential oncogene and therapeutic target in breast cancer. Cells 2022;11.","DOI":"10.20944\/preprints202212.0011.v1"},{"key":"784_CR39","doi-asserted-by":"publisher","first-page":"14455","DOI":"10.1074\/jbc.RA118.003279","volume":"293","author":"M Chen","year":"2018","unstructured":"Chen M, Zhang H, Shi ZB, Li YH, Zhang XM, Gao ZY, et al. The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer. J Biol Chem. 2018;293:14455\u201369.","journal-title":"J Biol Chem"},{"key":"784_CR40","doi-asserted-by":"crossref","unstructured":"Zhang H, Lin MB, Dong C, Tang Y, An LW, Ju JY, et al. An MST4-p\u03b2-catenin signaling axis controls intestinal stem cell and tumorigenesis. Adv Sci 2021;8.","DOI":"10.1002\/advs.202004850"},{"key":"784_CR41","doi-asserted-by":"publisher","first-page":"7889","DOI":"10.1002\/jcp.29443","volume":"235","author":"P Dent","year":"2020","unstructured":"Dent P, Booth L, Poklepovic A, Martinez J, Von Hoff D, Hancock JF. Neratinib degrades MST4 via autophagy that reduces membrane stiffness and is essential for the inactivation of PI3K, ERK1\/2, and YAP\/TAZ signaling. J Cell Physiol. 2020;235:7889\u201399.","journal-title":"J Cell Physiol"},{"key":"784_CR42","doi-asserted-by":"crossref","unstructured":"Caputo M, Xia Y, Anand SK, Cansby E, Andersson E, Marschall HU, et al. STE20-type kinases MST3 and MST4 promote the progression of hepatocellular carcinoma: Evidence from human cell culture and expression profiling of liver biopsies. Faseb J 2023;37.","DOI":"10.1096\/fj.202300397RR"},{"key":"784_CR43","doi-asserted-by":"crossref","unstructured":"Fan XL, Cui L, Zeng Y, Song WH, Gaur U, Yang MY. 14-3-3 Proteins Are on the Crossroads of Cancer, Aging, and Age-Related Neurodegenerative Disease. Int J Mol Sci. 2019;20.","DOI":"10.3390\/ijms20143518"},{"key":"784_CR44","doi-asserted-by":"crossref","unstructured":"Fromond C, Chene L, Soude A, Barth M, Montalbetti C, Broqua P. A rational approach for discovery of inhibitors of YAP-TEAD interaction. Cancer Res. 2015;75.","DOI":"10.1158\/1538-7445.AM2015-2200"},{"key":"784_CR45","doi-asserted-by":"crossref","unstructured":"Kumar R, Toh J, Thian J, Mohideen NF, Sun JL, Chakraborty S, et al. Identification of small molecule Pan-TEAD inhibitors disrupting YAP-TEAD protein-protein interaction and targeting gastric cancer cells. Cancer Res. 2024;84.","DOI":"10.1158\/1538-7445.AM2024-LB033"},{"key":"784_CR46","doi-asserted-by":"crossref","unstructured":"Tang TT, Konradi AW, Feng Y, Peng X, Qiao S, Post L. Targeting the Hippo-YAP pathway with novel small-molecule inhibitors of the YAP-TEAD transcription activity. Cancer Res. 2019;79.","DOI":"10.1158\/1538-7445.AM2019-2693"},{"key":"784_CR47","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.4314\/tjpr.v17i7.5","volume":"17","author":"JR Zhang","year":"2018","unstructured":"Zhang JR, Pan Y, Liao DH, Tang JY, Yao DW. Peptide 17, an inhibitor of YAP\/TEAD4 pathway, mitigates lung cancer malignancy. Trop J Pharm Res. 2018;17:1255\u201362.","journal-title":"Trop J Pharm Res"},{"key":"784_CR48","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41589-022-01061-z","volume":"18","author":"FL Li","year":"2022","unstructured":"Li FL, Fu V, Liu GB, Tang T, Konradi AW, Peng X, et al. Hippo pathway regulation by phosphatidylinositol transfer protein and phosphoinositides. Nat Chem Biol. 2022;18:1076\u2013.","journal-title":"Nat Chem Biol"},{"key":"784_CR49","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/j.molcel.2022.03.027","volume":"82","author":"SX Qi","year":"2022","unstructured":"Qi SX, Zhu YW, Liu XC, Li PY, Wang YB, Zeng Y, et al. WWC proteins mediate LATS1\/2 activation by Hippo kinases and imply a tumor suppression strategy. Mol Cell. 2022;82:1850\u2013.","journal-title":"Mol Cell"},{"key":"784_CR50","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ccell.2020.05.019","volume":"38","author":"Y Tang","year":"2020","unstructured":"Tang Y, Fang GM, Guo FH, Zhang H, Chen XX, An LW, et al. Selective Inhibition of STRN3-Containing PP2A Phosphatase Restores Hippo Tumor-Suppressor Activity in Gastric Cancer. Cancer Cell. 2020;38:115\u2013.","journal-title":"Cancer Cell"},{"key":"784_CR51","doi-asserted-by":"crossref","unstructured":"Meng ZP, Moroishi T, Mottier-Pavie V, Plouffe SW, Hansen CG, Hong AW, et al. MAP4K family kinases act in parallel to MST1\/2 to activate LATS1\/2 in the Hippo pathway. Nat Commun. 2015;6.","DOI":"10.1038\/ncomms9357"},{"key":"784_CR52","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/s43018-024-00797-y","volume":"5","author":"EA Chapeau","year":"2024","unstructured":"Chapeau EA, Sansregret L, Galli GG, Chene P, Wartmann M, Mourikis TP, et al. Author Correction: Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers. Nat Cancer. 2024;5:1130.","journal-title":"Nat Cancer"},{"key":"784_CR53","doi-asserted-by":"publisher","first-page":"201077","DOI":"10.1016\/j.omton.2025.201077","volume":"33","author":"S Inano","year":"2025","unstructured":"Inano S, Takaori-Kondo A, Nakajima T. Targeted degradation of KRAS and induction of bystander effects by a modular bioPROTAC. Mol Ther Oncol. 2025;33:201077.","journal-title":"Mol Ther Oncol"},{"key":"784_CR54","doi-asserted-by":"publisher","first-page":"9374","DOI":"10.1038\/s41467-025-64426-7","volume":"16","author":"R Zhou","year":"2025","unstructured":"Zhou R, Wang H, Zhang GM, Liu Y, Liu XL, Li Z, et al. Targeted degradation of endogenous YAP by nanobody bioPROTAC inhibits tumor progression. Nat Commun. 2025;16:9374.","journal-title":"Nat Commun"},{"key":"784_CR55","doi-asserted-by":"publisher","first-page":"e114558","DOI":"10.15252\/embj.2023114558","volume":"42","author":"Y Sun","year":"2023","unstructured":"Sun Y, Jin X, Meng J, Guo F, Chen T, Zhao X, et al. MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression. EMBO J. 2023;42:e114558.","journal-title":"EMBO J"},{"key":"784_CR56","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1042\/CS20241916","volume":"139","author":"H Ungefroren","year":"2025","unstructured":"Ungefroren H. PDCD10\/CCM3, a potential target for pancreatic ductal adenocarcinoma? Clin Sci (Lond). 2025;139:281\u20136.","journal-title":"Clin Sci (Lond)"},{"key":"784_CR57","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/S0092-8674(00)80487-0","volume":"91","author":"MB Yaffe","year":"1997","unstructured":"Yaffe MB, Rittinger K, Volinia S, Caron PR, Aitken A, Leffers H, et al. The structural basis for 14-3-3:phosphopeptide binding specificity. Cell. 1997;91:961\u201371.","journal-title":"Cell"},{"key":"784_CR58","doi-asserted-by":"publisher","first-page":"17237","DOI":"10.1073\/pnas.0605779103","volume":"103","author":"XW Yang","year":"2006","unstructured":"Yang XW, Lee WH, Sobott F, Papagrigoriou E, Robinson CV, Grossmann JG, et al. Structural basis for protein-protein interactions in the 14-3-3 protein family. P Natl Acad Sci USA. 2006;103:17237\u201342.","journal-title":"P Natl Acad Sci USA"},{"key":"784_CR59","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1016\/j.febslet.2012.10.048","volume":"586","author":"NN Sluchanko","year":"2012","unstructured":"Sluchanko NN, Gusev NB. Oligomeric structure of 14-3-3 protein: What do we know about monomers? Febs Lett. 2012;586:4249\u201356.","journal-title":"Febs Lett"},{"key":"784_CR60","doi-asserted-by":"crossref","unstructured":"Trosanov\u00e1 Z, Lousa P, Kozelekov\u00e1 A, Brom T, Gasparik N, Tungli J, et al. Quantitation of Human 14-3-3? Dimerization and the Effect of Phosphorylation on Dimer-monomer Equilibria. J Mol Biol. 2022;434.","DOI":"10.1016\/j.jmb.2022.167479"},{"key":"784_CR61","doi-asserted-by":"publisher","first-page":"C723","DOI":"10.1152\/ajpcell.00462.2010","volume":"300","author":"KW Dunn","year":"2011","unstructured":"Dunn KW, Kamocka MM, McDonald JH. A practical guide to evaluating colocalization in biological microscopy. Am J Physiol Cell Physiol. 2011;300:C723\u2013742.","journal-title":"Am J Physiol Cell Physiol"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00784-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00784-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00784-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T08:09:14Z","timestamp":1779350954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00784-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["784"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00784-6","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the IACUC of Tongji University (approval ID: SHDSYY-2023-P0011), ensuring compliance with ethical standards for animal research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Y.T., Z.Z., L.A., L.T. and Zhangting Zhao have filed a patent (2025114401585) for the MIP#1-3 in China.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}